GENE ONLINE|News &
Opinion
Blog

Trials & Approvals
Trials & Approvals Bone Health
Korean Ginseng Gets Approved for a Functional Ingredient for Bone Health
2020-09-13
Trials & Approvals Lung Cancer
GAVRETO Grabs FDA Approval for Metastatic RET Fusion-Positive NSCLC
2020-09-08
Trials & Approvals Epigenetic Modifier
Bristol Myers Squibb Notches Key Regulatory Win for Oral Formulation of Epigenetic Modifier
2020-09-06
Trials & Approvals Non-Hodgkin Lymphoma
Chinese Biopharma Makes Potential Headway Against Unique Type of Non-Hodgkin Lymphoma
2020-09-06
Trials & Approvals CD38
Spotlight: Cancer Drug Licensed from Danish Antibody Developer Continues to Reap Benefits for Janssen
2020-09-04
Trials & Approvals MiniMed 770G System
Medtronic Bags FDA Authorization for Pioneering Medical Device to Combat Pediatric Diabetes
2020-09-02
Trials & Approvals
Bristol-Myers-Squibb Anticipates FDA Approval for CC-486 as a Treatment for Acute Myeloid Leukemia
2020-08-30
Trials & Approvals ESCC
Keytruda Receives Two New Approvals in Japan
2020-08-30
Trials & Approvals
Novartis’ Asciminib Shines in Chronic Myeloid Leukemia Trial
2020-08-28
Trials & Approvals Liquid Biopsy
FDA Okays Foundation Medicine’s Comprehensive Liquid Biopsy Test
2020-08-27
COVID-19
AstraZeneca Initiates Phase 1 Trial of COVID-19 Antibody Treatment in the UK
2020-08-26
Trials & Approvals Multiple Sclerosis
Novartis’ Kesimpta Notches FDA Approval as Targeted B-cell Therapy for Patients with Relapsing MS
2020-08-23
Trials & Approvals
Genentech’s IL-6 Inhibitor Bags FDA Approval for Neuromyelitis Optica Spectrum Disorder
2020-08-19
Trials & Approvals Clostridium Difficile
Seres Therapeutics’ Microbiome Therapy for Recurrent C. difficile Infections, Shines in Phase 3
2020-08-12
Trials & Approvals
Genentech Enters Spinal Muscular Atrophy Market with Risdiplam’s FDA Approval
2020-08-11
1 … 39 40 41 42 43 … 50
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top